1. Home
  2. ANTX vs VWAV Comparison

ANTX vs VWAV Comparison

Compare ANTX & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.92

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$2.96

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANTX
VWAV
Founded
2017
2024
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
139.7M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ANTX
VWAV
Price
$4.92
$2.96
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
353.1K
562.1K
Earning Date
05-13-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$3.13
52 Week High
$6.91
$15.80

Technical Indicators

Market Signals
Indicator
ANTX
VWAV
Relative Strength Index (RSI) 58.69 30.82
Support Level $3.91 N/A
Resistance Level $5.13 $6.64
Average True Range (ATR) 0.36 0.34
MACD 0.03 -0.07
Stochastic Oscillator 80.00 0.64

Price Performance

Historical Comparison
ANTX
VWAV

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: